National Research Society (NASDAQ: NRCGet a rating) benefited from a significant drop in short-term interest rates in October. As of October 31, there was short interest totaling 230,700 shares, down 28.1% from the total of 320,800 shares as of October 15. Based on an average daily volume of 44,200 shares, the short interest ratio is currently 5.2 days. Approximately 1.6% of the company’s shares are sold short.

National research stock down 2.6%

National research stock traded down $1.05 in Friday’s midday session, hitting $39.33. 38,614 shares were traded, against an average volume of 50,610. National Research has a 52-week low of $30.93 and a 52-week high of $48.55. The stock has a market capitalization of $990.72 million, a price/earnings ratio of 28.50 and a beta of 0.50. The company’s 50-day moving average price is $39.01 and its 200-day moving average price is $36.91. The company has a quick ratio of 1.31, a current ratio of 1.20 and a debt ratio of 0.28.

Announcement of the National Research Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, October 14. Shareholders of record on Friday, September 30 received a dividend of $0.24. This represents a dividend of $0.96 on an annualized basis and a yield of 2.44%. The ex-dividend date was Thursday, September 29. National Research’s payout ratio is 69.57%.

Insider buying and selling at National Research

Separately, major shareholder Amandla Mk Trust sold 795 National Research shares in a trade dated Friday, September 30. The shares were sold at an average price of $40.59, for a total transaction of $32,269.05. Following the completion of the transaction, the insider now directly owns 4,660,844 shares of the company, valued at $189,183,657.96. The sale was disclosed in a filing with the Securities & Exchange Commission, accessible via this link. In the past ninety days, insiders have sold 246,555 shares of the company valued at $9,814,070. Company insiders hold 2.00% of the company’s shares.

Institutional entries and exits

A number of hedge funds and other institutional investors have recently increased or reduced their stake in NRC. BlackRock Inc. raised its position in National Research stocks by 0.3% in the first quarter. BlackRock Inc. now owns 921,600 shares of the company valued at $36,541,000 after purchasing an additional 3,053 shares during the period. Conestoga Capital Advisors LLC raised its position in National Research stocks by 0.4% in the second quarter. Conestoga Capital Advisors LLC now owns 731,135 shares of the company valued at $27,988,000 after purchasing an additional 2,838 shares during the period. State Street Corp raised its position in National Research shares 6.3% in the first quarter. State Street Corp now owns 308,746 shares of the company valued at $12,315,000 after purchasing an additional 18,237 shares during the period. Touchstone Capital Inc. raised its position in National Research shares by 0.5% in the third quarter. Touchstone Capital Inc. now owns 285,505 shares of the company valued at $11,363,000 after purchasing an additional 1,541 shares during the period. Finally, Northern Trust Corp increased its position in National Research shares by 8.7% in the second quarter. Northern Trust Corp now owns 274,454 shares of the company valued at $10,507,000 after purchasing an additional 22,023 shares during the period. 67.51% of the shares are currently held by hedge funds and other institutional investors.

National Research Company Profile

(Get a rating)

National Research Corporation provides analytics and insights that make it easier to measure and improve the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable insights and analytics to healthcare organizations on a range of mission-critical and constituent-related elements, including patient experience, service recovery, care transitions , health risk assessments, employee engagement, reputation management and brand. loyalty.

Featured articles

This instant alert was powered by MarketBeat’s narrative science technology and financial data to provide readers with the fastest and most accurate reports. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send questions or comments about this story to [email protected]

Before you consider national search, you’ll want to hear this.

MarketBeat tracks daily the highest rated and most successful research analysts on Wall Street and the stocks they recommend to their clients. MarketBeat has identified the five actions that top analysts are quietly whispering to their clients to buy now before the market spreads…and National Research was not on the list.

While National Research currently has an “N/A” rating among analysts, top-rated analysts believe these five stocks are better buys.

See the five actions here